15-34792014-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005159.5(ACTC1):c.808+76G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.274 in 1,525,606 control chromosomes in the GnomAD database, including 58,871 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 5161 hom., cov: 33)
Exomes 𝑓: 0.28 ( 53710 hom. )
Consequence
ACTC1
NM_005159.5 intron
NM_005159.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.702
Genes affected
ACTC1 (HGNC:143): (actin alpha cardiac muscle 1) Actins are highly conserved proteins that are involved in various types of cell motility. Polymerization of globular actin (G-actin) leads to a structural filament (F-actin) in the form of a two-stranded helix. Each actin can bind to four others. The protein encoded by this gene belongs to the actin family which is comprised of three main groups of actin isoforms, alpha, beta, and gamma. The alpha actins are found in muscle tissues and are a major constituent of the contractile apparatus. Defects in this gene have been associated with idiopathic dilated cardiomyopathy (IDC) and familial hypertrophic cardiomyopathy (FHC). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 15-34792014-C-G is Benign according to our data. Variant chr15-34792014-C-G is described in ClinVar as [Benign]. Clinvar id is 1292062.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-34792014-C-G is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.337 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.253 AC: 38489AN: 152018Hom.: 5158 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
38489
AN:
152018
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.276 AC: 379105AN: 1373470Hom.: 53710 Cov.: 20 AF XY: 0.278 AC XY: 190899AN XY: 686918 show subpopulations
GnomAD4 exome
AF:
AC:
379105
AN:
1373470
Hom.:
Cov.:
20
AF XY:
AC XY:
190899
AN XY:
686918
Gnomad4 AFR exome
AF:
AC:
5035
AN:
31608
Gnomad4 AMR exome
AF:
AC:
16259
AN:
43198
Gnomad4 ASJ exome
AF:
AC:
6572
AN:
25400
Gnomad4 EAS exome
AF:
AC:
14033
AN:
39032
Gnomad4 SAS exome
AF:
AC:
27859
AN:
83474
Gnomad4 FIN exome
AF:
AC:
13074
AN:
52400
Gnomad4 NFE exome
AF:
AC:
279815
AN:
1036838
Gnomad4 Remaining exome
AF:
AC:
15234
AN:
57398
Heterozygous variant carriers
0
13901
27801
41702
55602
69503
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
9266
18532
27798
37064
46330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.253 AC: 38496AN: 152136Hom.: 5161 Cov.: 33 AF XY: 0.255 AC XY: 18940AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
38496
AN:
152136
Hom.:
Cov.:
33
AF XY:
AC XY:
18940
AN XY:
74362
Gnomad4 AFR
AF:
AC:
0.163593
AN:
0.163593
Gnomad4 AMR
AF:
AC:
0.344972
AN:
0.344972
Gnomad4 ASJ
AF:
AC:
0.256344
AN:
0.256344
Gnomad4 EAS
AF:
AC:
0.341676
AN:
0.341676
Gnomad4 SAS
AF:
AC:
0.334372
AN:
0.334372
Gnomad4 FIN
AF:
AC:
0.251606
AN:
0.251606
Gnomad4 NFE
AF:
AC:
0.27133
AN:
0.27133
Gnomad4 OTH
AF:
AC:
0.259242
AN:
0.259242
Heterozygous variant carriers
0
1485
2969
4454
5938
7423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
396
792
1188
1584
1980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1160
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at